Synthetic Biologics & Proteon Therapeutics Stock Prices Soar 30% & 45%, Respectively, On News Of Designations From The FDA
Thursday, May 11, 2017 10:17 AM EDT
The FDA handed out new breakthrough therapy designations for a whole slate of biotech drugs in the clinic and investors are still cheer each announcement with a big spike in stock prices: PRTO stock went up 46% on Wednesday; SYN's is up 30% today.